H3Africa Collaborative Centers

AWI-Gen 2: Genomic and Environmental Risk Factors for Cardiometabolic Disease in Africans


The Goal

AWI-Gen is working to understand how genes, environment, and lifestyle affect cardiovascular and metabolic health across Africa and to uncover new insights that could help to improve the health of Africans.

Principal Investigator:

Prof Michele Ramsay

University of Witwatersrand


The Problem

Due to advances in the field of genetics and genomics, researchers now have the ability to understand how one’s DNA and their environment can play a role in their susceptibility to obesity, hypertension, and diabetes – but only in western populations. African populations have been routinely omitted from this fundamental research, keeping them from accessing basic public health strategies.

Project Strategy

  1. Survey 12,000 participants across the continent for information regarding lifestyle, environment, and medical history.
  2. Collect blood and urine samples from participants to measure genomic and metabolic health factors.
  3. Use this information to explore genetic contributions and gene-by-environment interactions on susceptibility for traits like obesity, hypertension and diabetes.
  4. Use insights to support development of better prevention and treatment strategies and to inform public policy.

Outcomes to Date

So far, AWI-Gen has found that obesity disproportionately affects women in southern and eastern Africa and is linked to increased prevalence of diabetes. There is regional variation in the prevalence of hypertension, with a lack of awareness of high blood pressure,. Although some are aware of their status and on medication, their blood pressure remains poorly controlled. Genetic studies have shown that people from the same region and ethnicity tend to cluster together, and that there are differences between the people from western, eastern and southern Africa. Geographic isolation and local adaption to their environments may in part account for these differences.

Project Sites

A. South Africa, WITS Health Consortium, University of the Witwatersrand

B. South Africa, University of Limpopo

C. Ghana, Navrongo Health Research Center

D. Burkina Faso, Clinical Research Center of Nanoro

E. Kenya, African Population and Health Research Center

Non-African Collaborators
USA: Harvard University, Stanford University, University of Colorado
UK: University of Bristol, University of Leicester & Wellcome Trust Sanger Institut

October 16, 2018

AWI-GEN 2: Genomic and Environmental Risk Factors for Cardiometabolic Disease in Africans

AWI-Gen is the Africa Wits-INDEPTH partnership for Genomic Studies, an NIH funded and university supported Collaborative Center of the Human Heredity and Health in Africa
April 6, 2018

Eyes of Africa: The Genetics of Blindness

“Eyes of Africa: The Genetics of Blindness” will address the staggering economic, societal, and personal cost of irreversible blindness in Africa. The most common cause of permanent
April 4, 2018

Genomic Characterization and Surveillance of Microbial Threats in West Africa

Overall Recent viral outbreaks in West Africa, specifically the 2013-16 Ebola Virus Outbreak, shed light on the many limitations of current surveillance and diagnostics in the region’s public health systems. Tools for rapid, accurate
April 4, 2018

Genomic and Environmental Risk Factors for Cardiometabolic Disease in Africans

The long-term vision of the Collaborative Centre (CC) is to build sustainable capacity in Africa for research that leads to an understanding of the interplay between genetic, epigenetic and
April 4, 2018

SickleGenAfrica: Sickle Cell Disease Genomics Network of Africa

Sickle cell disease (SCD) is the commonest genetic disorder in the World. It is most prevalent in Africa. We have established SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa to build capacity locally to enable African scientists study genomics of SCD on the continent
April 4, 2018

Center for Research on the Respiratory Microbiota of African Children (ReMAC)

Center for Research on the Respiratory Microbiota of African Children (ReMAC): Abstract The microbiota (community of microorganisms) of the upper airways plays a key role in the development of lower respiratory tract infection (LRTI) in children. Most of the important bacterial LRTI pathogens also colonize the
April 4, 2018

Stroke Investigative Research & Educational Network (SIREN)

troke is the leading cause of neurological hospital admissions and a leading cause of deaths in Africa. Indeed, with an estimated stroke incidence of up to 315/100,000 population, about 6 Africans develop stroke every minute. Up to 3.2 million Africans develop first-incident stroke every year. Moreover, the burden
April 4, 2018

Collaborative African Genomics Network (CAfGEN)

Advanced genetic and genomic technologies promise to transform our understanding and approach to human health and disease. Such genomic analyses are now common in Western populations of European descent.
April 4, 2018

H3Africa Kidney Disease Research Network

It is estimated more than 500,000 individuals succumb to end stage renal disease annually in sub-Saharan Africa with an additional 50 million people suffering from pre-dialysis chronic kidney disease. Advanced genome-based analysis strategies, such as